Komori
Governance7600Japan Medical Dynamic Marketing,INC.Electrical and Precision Instruments

Notice Concerning Clarification of Management Responsibility and Promotion of the Performance Improvement Plan

In response to deteriorating performance, the company decided to reduce and voluntarily return a portion of executive compensation, while advancing improvement measures including sales recovery, cost reductions, headcount reductions at its U.S. subsidiary, and reviews of expenses and inventory.

Worth reading
80Important
Scored from 1 of 5 sections
Direction
Deterioration
Direction inferred from the company’s description.
Scale
54
Reduction in annual total compensation for the Representative Director and President (approximately %)
Wording
Conditional
How definitive the wording is.

Contents of this filing

Changes this time

The company decided to reduce and voluntarily return a portion of executive compensation, not pay performance-linked compensation for the current fiscal year, not grant stock-based compensation, and implement performance improvement measures.

この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。

Contents of this filing
ItemDetails
Changes this timeThe company decided to reduce and voluntarily return a portion of executive compensation, not pay performance-linked compensation for the current fiscal year, not grant stock-based compensation, and implement performance improvement measures.
Items this document does not state (7)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company recorded a significant operating loss and net loss attributable to owners of the parent for the cumulative second quarter of the fiscal year ending March 2027, revised its full-year consolidated earnings forecasts downward, and revised its year-end dividend forecast to zero. The company said it aims to achieve an early recovery in performance and stabilize its financial base.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Clarification of Management Responsibility and Promotion of the Performance Improvement Plan | Japan Medical Dynamic Marketing,INC. (7600) timely disclosure | Komori